Dr. Sulaiman Al Habib Medical Services Group revenue and financials

4013 · Tadawul · SAR

SAR 228.90+0.18%+SAR 0.40

Close · October 7, 2026

In the fiscal year ended December 2025, Dr. Sulaiman Al Habib Medical Services Group reported revenue of SAR 13.71B (+22.38% year over year). Net income was SAR 2.4B, a net margin of 17.5%.

Annual revenue · 2025: SAR 13.71B
  1. SAR 7.25B2021
  2. SAR 8.31B2022
  3. SAR 9.51B2023
  4. SAR 11.2B2024
  5. SAR 13.71B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+22.38%
2025 vs 2024
Net income growth
+3.72%
2025 vs 2024
Net margin
17.5%
2024: 20.7%

Financial data

Amounts in millions of SAR; per-share values in SAR; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue4,0063,4363,7013,4633,3843,1583,1292,9772,5742,5212,4862,443
Cost of revenue2,7842,4802,6522,4132,3182,1292,1471,9841,6961,6441,6351,599
Gross profit1,2229561,0501,0501,0661,028982992878877852843
Selling, general and administrative452368367384421402358368326321318291
Operating income770588682666645626624624552556534552
EBIT770588682666645626624624552556534552
EBITDA992801770837808777692737644638563630
Interest expense10410490.886.083.478.673.150.923.015.817.317.6
Pre-tax income726540679635616590638614573588531582
Income tax20.626.2-5.19.613.29.94.810.512.015.5-15.826.9
Net income663503651602591557614596555551525545
Net income to common shareholders663503651602591557614596555551525545
Basic EPS1.891.441.861.721.691.591.751.701.591.571.501.56
Diluted EPS1.891.441.861.721.691.591.751.701.591.571.501.56
Average shares (basic)350350350350350350350350350350350350
Average shares (diluted)350350350350350350350350350350350350
Dividend per share1.331.011.311.211.191.121.231.201.171.171.151.17